The trajectory of companies tied to iconic drugs like Viagra presents a nuanced investment landscape . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the patent expiration in key territories has introduced substantial uncertainty . Investors are now assessing the consequences of generi